IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury

Kidney International

Volumn 87, Issue 2, 2015, Pages 396-408

  Yang, Yunbo ^a   Zhang, Zhu Xu ^a,b   Lian, Dameng ^a   Haig, Aaron ^b   Bhattacharjee, Rabindra N ^a   Jevnikar, Anthony M ^a,b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

IL 37; ischemia reperfusion injury; tubular epithelial cell

Indexed keywords

CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 37; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; IL37 PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 18 RECEPTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RENAL PROTECTION; REPERFUSION INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL LINE; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; INJURIES; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; CELL LINE; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-18; KIDNEY; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-18; REPERFUSION INJURY; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84922240662     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.295     Document Type: Article

References (47)

1. Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant 2011; 11: 2279-2296.
2. Grinyo JM. Role of ischemia-reperfusion injury in the development of chronic renal allograft damage. Transplant Proc 2001; 33: 3741-3742.
3. Joosten SA, Sijpkens YW, van Kooten C et al. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005; 68: 1-13.
4. van der Vliet JA, Warle MC. The need to reduce cold ischemia time in kidney transplantation. Curr Opin Organ Transplant 2013; 18: 174-178.
5. Dunn E, Sims JE, Nicklin MJ et al. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol 2001; 22: 533-536.
6. Busfield SJ, Comrack CA, Yu G et al. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 2000; 66: 213-216.
7. Kumar S, McDonnell PC, Lehr R et al. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 2000; 275: 10308-10314.
8. Nold MF, Nold-Petry CA, Zepp JA et al. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11: 1014-1022.
9. Pan G, Risser P, Mao W et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 2001; 13: 1-7.
10. Bufler P, Azam T, Gamboni-Robertson F et al. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA 2002; 99: 13723-13728.
11. Bulau AM, Nold MF, Li S et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc Natl Acad Sci USA 2014; 111: 2650-2655.
12. Zhao PW, Jiang WG, Wang L et al. Plasma levels of IL-37 and correlation with TNF-Alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 2014; 9: e95346.
13. Imaeda H, Takahashi K, Fujimoto T et al. Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol 2013; 172: 410-416.
14. McNamee EN, Masterson JC, Jedlicka P et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 2011; 108: 16711-16716.
15. Ting YT, Coates PT, Walker RJ et al. Urinary tubular biomarkers as potential early predictors of renal allograft rejection. Nephrology (Carlton) 2012; 17: 11-16.
16. Stroo I, Stokman G, Teske GJ et al. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol 2010; 22: 433-442.
17. Amura CR, Renner B, Lyubchenko T et al. Complement activation and tolllike receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol 2012; 52: 249-257.
18. Netea MG, Kullberg BJ, Verschueren I et al. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 2000; 30: 3057-3060.
19. Blom L, Poulsen LK. IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures. J Immunol 2012; 189: 4331-4337.
20. Wu H, Craft ML, Wang P et al. IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol 2008; 19: 2331-2341.
21. Leslie JA, Meldrum KK. The role of interleukin-18 in renal injury. J Surg Res 2008; 145: 170-175.
22. Richard M, Arfi A, Seguin J et al. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery. Gene Ther 2009; 16: 746-756.
23. Arad U, Zeira E, El-Latif MA et al. Liver-Targeted gene therapy by SV40-based vectors using the hydrodynamic injection method. Hum Gene Ther 2005; 16: 361-371.
24. Jevnikar AM, Mannon RB. Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol 2008; 3(Suppl 2): S56-S67.
25. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109: e102-e107.
26. Zager RA, Vijayan A, Johnson AC. Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury stress response. Am J Physiol Renal Physiol 2012; 303: F139-F148.
27. Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int 2011; 80: 29-40.
28. de Vries DK, Lindeman JH, Tsikas D et al. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am J Transplant 2009; 9: 1574-1584.
29. Molinas SM, Cortes-Gonzalez C, Gonzalez-Bobadilla Y et al. Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury. Nephron Exp Nephrol 2009; 112: e10-e19.
30. Jevnikar AM, Brennan DC, Singer GG et al. Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int 1991; 40: 203-211.
31. Tete S, Tripodi D, Rosati M et al. IL-37 (IL-1F7) the newest antiinflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol 2012; 25: 31-38.
32. Kim G, Kronenberg M. Cooling the fires of inflammation. Proc Natl Acad Sci USA 2011; 108: 16493-16494.
33. Boraschi D, Lucchesi D, Hainzl S et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011; 22: 127-147.
34. Kumar S, Hanning CR, Brigham-Burke MR et al. Interleukin-1F7B (IL-1H4/ IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 2002; 18: 61-71.
35. Nozaki Y, Kinoshita K, Yano T et al. Signaling through the interleukin-18 receptor alpha attenuates inflammation in cisplatin-induced acute kidney injury. Kidney Int 2012; 82: 892-902.
36. Kim SH, Reznikov LL, Stuyt RJ et al. Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain. J Immunol 2001; 166: 148-154.
37. Thomassen E, Bird TA, Renshaw BR et al. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J Interferon Cytokine Res 1998; 18: 1077-1088.
38. Kojima H, Takeuchi M, Ohta T et al. Interleukin-18 activates the IRAKTRAF6 pathway in mouse EL-4 cells. Biochem Biophys Res Commun 1998; 244: 183-186.
39. Tripodi D, Maccauro G, Anogeianaki A et al. Impact of IL-18 on inflammation. J Biol Regul Homeost Agents 2011; 25: 7-11.
40. Li W, Yamamoto H, Kubo S et al. Modulation of innate immunity by IL-18. J Reprod Immunol 2009; 83: 101-105.
41. Doi K, Katagiri D, Negishi K et al. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int 2012; 82: 1114-1120.
42. Sprenkle P, Russo P. Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate? Arch Esp Urol 2013; 66: 99-114.
43. Sakai N, Van Sweringen HL, Belizaire RM et al. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 2012; 27: 1609-1616.
44. Rahman P, Sun S, Peddle L et al. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006; 54: 2321-2325.
45. Powell JT, Tsapepas DS, Martin ST et al. Managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline. Clin Transplant 2013; 10: 12121.
46. Wang S, Zhang ZX, Yin Z et al. Anti-IL-2 receptor antibody decreases cytokine-induced apoptosis of human renal tubular epithelial cells (TEC). Nephrol Dial Transplant 2011; 26: 2144-2153.
47. Du C, Guan Q, Diao H et al. Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. Am J Physiol Renal Physiol 2006; 290: F1044-F1054.